Literature DB >> 2679035

Antihypertensive and anti-ischemic effects of nicardipine and nitroprusside in patients undergoing coronary artery bypass grafting.

H B van Wezel1, J J Koolen, C A Visser, J P Dijkhuis, I Vergroesen, A C Moulijn, L Deen.   

Abstract

The efficacy of nicardipine vs nitroprusside in controlling hypertension after sternotomy was compared in 120 patients undergoing coronary artery bypass grafting and anesthetized with fentanyl (100 micrograms/kg). All had good left ventricular function and had been receiving long term oral beta-blocking therapy. Patients were randomly allocated to 1 of 3 groups: group C, the control (n = 40), received no vasodilator; group N (n = 40) received intravenous nicardipine at an initial rate of 3 micrograms/kg/min; and group S (n = 40) received intravenous nitroprusside at an initial rate of 1 microgram/kg/min. Vasodilator infusion was begun before surgery and infusion rates were adjusted to maintain systolic blood pressure between 80 and 120% of postintubation (baseline) values. Additional measurements were obtained before incision and after sternotomy. In groups N and S, arterial blood pressure was effectively controlled in all patients. Before the incision, pulmonary artery pressure decreased in group S and systemic vascular resistance decreased in groups N and S. After sternotomy, mean arterial pressure, heart rate, pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac index and rate-pressure product increased in group C. At this time, pulmonary artery pressure returned to baseline values in group S. In groups N and S, heart rate, cardiac index and rate-pressure product increased, but, compared with baseline values, systemic vascular resistance remained low after sternotomy. Ischemic changes were seen in the electrocardiogram in 11 patients (28%) in group C, 10 patients (25%) in group S and 4 patients (10%) in group N. The concentration of creatine phosphokinase MB was not significantly different in the first 24 postoperative hours in any group.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2679035     DOI: 10.1016/0002-9149(89)90977-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications.

Authors:  Monique P Curran; Dean M Robinson; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Effects and interaction of nicardipine and volatile anesthetics in the rat heart-lung preparation.

Authors:  Satoshi Kashimoto; Toshihiro Nakamura; Masaki Kume; Akihiko Nonaka; Teruo Kumazawa
Journal:  J Anesth       Date:  1994-03       Impact factor: 2.078

3.  Therapeutic Interchange of Clevidipine For Sodium Nitroprusside in Cardiac Surgery.

Authors:  Joseph E Cruz; Zachariah Thomas; David Lee; David M Moskowitz; Jeff Nemeth
Journal:  P T       Date:  2016-10

Review 4.  Strategies for managing perioperative hypertension.

Authors:  Ronak G Desai; Muhammad Muntazar; Michael E Goldberg
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

Review 5.  Nicardipine. A review of its pharmacology and therapeutic efficacy in older patients.

Authors:  J E Frampton; D Faulds
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.